2 terminated, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
Follow 35Pharma Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction HS135, Placebo - Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension | Phase 1 | Terminated | 35Pharma Inc | 4 | 2025-01-23 | 2025-09-04 |
| Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects HS235, Placebo - Overweight and Obesity | Phase 1 | Completed | 35Pharma Inc | 39 | 2024-11-28 | 2025-12-30 |
| A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults HS135 - Pulmonary Arterial Hypertension (PAH) | Phase 1 | Terminated | 35Pharma Inc | 5 | 2024-10-23 | 2025-05-30 |
Hypertension, Pulmonary (1) · Obesity (1) · Overweight (1) · Pulmonary Arterial Hypertension (1)
Canada (2) · Germany (1) · United States (1)